Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hormone Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005848
What this trial is testing

R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center 7
Not applicableStudy completedNCT02398526
What this trial is testing

Pain Evaluation in Radium-223 Treated Castration Resistant Prostate Cancer Patients With Bone Metastases

Who this might be right for
Castration-Resistant Prostatic Cancer
Bayer 363
Testing effectiveness (Phase 2)Study completedNCT00136526
What this trial is testing

Docetaxel and Diethylstilbestrol in the Treatment of Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
University of Washington 30
Large-scale testing (Phase 3)Looking for participantsNCT07723248
What this trial is testing

Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

Who this might be right for
Metastatic Castration Resistant Prostate Cancer
ORIC Pharmaceuticals 600
Early research (Phase 1)UnknownNCT00441571
What this trial is testing

Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Cytogen Corporation 30
Early research (Phase 1)Study completedNCT00635596
What this trial is testing

Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer

Who this might be right for
Solid Tumors
Amgen Research (Munich) GmbH 65
Testing effectiveness (Phase 2)WithdrawnNCT00084565
What this trial is testing

Paclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Fox Chase Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT04965766
What this trial is testing

Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerAdvanced Breast Cancer
Gustave Roussy, Cancer Campus, Grand Paris 139
Early research (Phase 1)Looking for participantsNCT06586957
What this trial is testing

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more
NiKang Therapeutics, Inc. 150
Not applicableStudy completedNCT00139204
What this trial is testing

Evaluation of the Effects of Chemotherapy on the Uptake and Retention of Carbon 11 Methionine in Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 20
Large-scale testing (Phase 3)Study completedNCT01610284
What this trial is testing

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 1,147
Testing effectiveness (Phase 2)Study completedNCT00105053
What this trial is testing

Vaccine Treatment for Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
NewLink Genetics Corporation 8
Early research (Phase 1)Study completedNCT00519233
What this trial is testing

AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Astellas Pharma Inc 13
Testing effectiveness (Phase 2)Ended earlyNCT00585416
What this trial is testing

Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 23
Testing effectiveness (Phase 2)Study completedNCT00629525
What this trial is testing

RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer

Who this might be right for
Hormone Refractory Prostate Cancer
Daniel George, MD 35
Testing effectiveness (Phase 2)Study completedNCT00081601
What this trial is testing

Study of CEP-701 in Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
Cephalon 30
Testing effectiveness (Phase 2)Study completedNCT00087139
What this trial is testing

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 124
Testing effectiveness (Phase 2)Study completedNCT00106301
What this trial is testing

Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228

Who this might be right for
Carcinoma, Renal CellProstatic Neoplasms
Celgene 2
Testing effectiveness (Phase 2)Study completedNCT00313781
What this trial is testing

Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)

Who this might be right for
Prostatic Neoplasms
Pfizer 204
Testing effectiveness (Phase 2)Study completedNCT00271687
What this trial is testing

A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasm MetastasisPalliative Care
AHS Cancer Control Alberta 30
Next Page